DOW Chemical

The following is only a fraction of the information that is available with the Implant Awareness Society. We now have the proof, through their own documents (300 pages), that the science was INDEED TRULY DONE. They choose to declare to the Medical Profession that silicone is inert, when indeed it is very toxic.

They provided the GREAT LIE TO THE WORLD for their own financial gain, true unbridled greed.

All silicone gel contains the same fluids previously mentioned; it bleeds through the silicone elastomer shell. According to the FDA report to the American Congress, 1992, this gel bleed is equivalent to silicone injections over a period of time. The report then states that there is no difference between a silicone injection and a broken implant (page 7 of the report). Silicone injections were made illegal because the injections resulted in deaths (page 3).

The FDA also knows that the implant’s life, because of the elastomer shell, is 5 to 7 years (page 29 in the FDA report), also mentioned in article 562 of these court documents because of the macrophage up-take.

Our own Canadian Health Protection Branch is also to have this same proof of safety provided to them for all Canadian women, nursing infants, and for the protection of the unborn fetus. The manufacturers took the silicone gel implants off the market because the burden of proof is on the manufacturer to prove safety. The HPB did not remove them.

Dr. Pierre Blais, an eminent specialist in implant design and failure proved that, since bodily fluids both enter and exit all breast implants, saline implants become septic very quickly from bodily fluids, fungus, and bacteria contained in the outdated saline (saline has a shelf-life of under one year). If expired, hospitals will not use saline to even wash a scratch. AND THIS IS CONSIDERED SAFE IN A WOMAN’S BODY FOR YEARS?

It has been established that a nursing infant can break an implant with a 1/4-pound nursing pull. Since Dr. Blais established that all breast implants become septic, it is obvious that some septic fluid can find its way into much of the surrounding breast tissue. Does a woman want these toxins in her nursing baby’s stomach? WE THINK NOT, YET HOW MANY DOCTORS TELL PREGNANT WOMEN WITH IMPLANTS NOT TO NURSE? Our society has yet to learn OF ONE.

Adella Matthew
President

Implant Awareness Society

Trial Exhibit #: 9.
Date: 00/00/00
Title: JOINT
VENTURE/CORPORATE CONTROL
Information: “Former Dow Chemical Employees Who ‘Transferred’ Or Joined Dow Corning,”.

.

Trial Exhibit #: 12.
Date: 00/00/00
Title: ACKNOWLEDGEMENT OF NEED FOR TESTING COMPLICATIONS: TISSUE REACTION KNOWLEDGE OF SYSTEMIC DISEASE SILICA
Information: W.D. Galloway reports on the “Analysis of Lifetime Carcinogenicity Study of Silicone Gels” conducted by Dow Corning under GLP regulations using Sprague-Dawley rats injected with Q7-2159A and MDE-0193 gels.

Galloway states:

Both of the gel-implanted groups showed a large number of cancers compared to the control group. Particularly striking was the number of sarcomas (principally fibrosarcomas) which occurred in the  treated groups.

The only obvious deficiency is that only one dose level was used. Ordinarily, three doses are used, and five are preferred. Based on the results obtained, I have little Doubt that NTP would classify these substances as likely animal carcinogens.

According to Dow Corning, … the tumors were peculiar to rats, the so called foreign body tumors.

Absent epidemiologic data, and without waiting for the results of additional lifetime studies, knowledge of the mechanism by which these tumors was induced is critical to estimate human risks. It is possible that the tumors were chemically induced, rather than being induced by a physical mechanism, as Dow suggests. If this is the case, then the argument that such tumors do not occur in man is untenable. If the tumors were chemically induced, the active agent is more likely to be one of the several chemicals
which make up the gel, rather than a metabolically produced reactive intermediate, since the tumors which did occur did not occur selectively in metabolically active organs such as the liver.

Recent studies have shown that siloxanes may act as estrogen-like substances and can enhance the growth of tumor cells.

.

Trial Exhibit #: 29.
Date: 00/00/00
Title: DOW CHEMICAL TESTING OF SILICONES IN BREAST IMPLANTS
RELIANCE ON DOW CHEMICAL
SILICONE IS INERT MYTH
Information: Booklet distributed by Dow Corning containing the November 1949 Rowe, Spencer, and Bass article entitled, “Toxicological Studies On Certain Commercial Silicones,” reprinted from The Journal of Industrial Hygiene and Toxicology, Vol. 30, No. 6, 332-352.

.

Trial Exhibit #: 43
Date: 00/00/50
Title: RELIANCE ON DOW CHEMICAL SILICONE IS INERT MYTH
Information: “Toxicological Studies On Certain Commercial Silicones, II. Two-Year Dietary Feeding Of DC Antifoam A To Rats,” by Rowe, Spencer, and Bass, published in Archives of Industrial Hygiene and Occupational medicine, Vol. 1, p. 539-544.

.

Trial Exhibit #: 78
Date: 10/09/57
Title: BIOLOGICAL ACTIVITY OF SILICONES KNOWLEDGE OF SYSTEMIC DISEASE
Information: Dr. Deichmann, University of Miami, writes to McGregor, Dow Corning, enclosing the results of the review of the six Dow Corning silicone compounds. He informs McGregor that all six compounds depressed the granulocytic elements of the peripheral (tail) blood of the female rats, and that the livers of rats fed Z-4141 were significantly heavier than the controls and demonstrated fatty infiltration or degeneration.

.

Trial Exhibit #: 80
Date: 11/27/57
Title: BIOLOGICAL ACTIVITY OF SILICONES RELIANCE ON DOW CHEMICAL
Information: Letter from Dr. William Deichmann, University of Miami, to Dr. R.R. McGregor at Dow Chemical (McGregor was actually at Dow Corning) with a copy to V.K. Rowe. Deichmann encloses a memo from a pathologist at the University of Miami. Based on this and a meeting with Dr. Irish, Deichmann decided to repeat the hematological studies in rats fed Z-4141.

.

Trial Exhibit #: 81
Date: 12/02/57
Title: BIOLOGICAL ACTIVITY OF SILICONES DOW CHEMICAL TESTING OF DOW CORNING PRODUCTS – ATHLETE’S FOOT RELIANCE ON DOW CHEMICAL
Information: Letter from Mark Wolf and checked by D.D. McCollister, Dow Chemical Biochemical Research, to R.R. McGregor of Dow Corning with a copy to J.H. McHard on “Results Of Skin Irritation Tests On XC-4032 [the material is being considered for treatment of athlete’s foot].” The formulation caused moderate irritation and damage within 24 hours of contact with covered skin. “It is recommended that the use of this formulation for Athlete’s Foot should be approached with caution.” Repeated prolonged contact caused development of moderate irritation and slight necrosis and slight exfoliation. The material consists of 43% Dow Corning 200 Fluid, 250 cs. and a Dow Chemical material, Dowicide 2.

Attached is the data sheet completed by Wolf and McCollister, a toxicology work sheet, “Request For Applications Testing, “and skin contact – irritation and patch test – skin test records. NOTE: The document is stamped, “This Report Is The Property Of The Dow Chemical Company

NOTE: Dow Chemical is providing advice and recommendations to Dow Corning on product applications.

.

Trial Exhibit #: 83
Date: 12/24/57
Title: BIOLOGICAL ACTIVITY OF SILICONES DOW CHEMICAL TESTING OF DOW CORNING PRODUCTS RELIANCE ON DOW CHEMICAL
Information: Letter from K.J. Olson and checked by D.D. McCollister, Dow Chemical Biochemical Research, to R.R. McGregor of Dow Corning with copies to J.H. McHard and H.H. Gay [Dow Chemical] on “Results Of Range Finding Toxicological Tests On Polymethyl Methylsiloxanes-2-Methylpropionate.” The material has a low acute oral toxicity, the undiluted material may produce slight pain and slight immediate conjunctivitis, it is irritating to the skin, and may produce hyperplasia of the hair follicles. “This reaction is manifested by ‘acneiform’ dermititis [sic] in humans.” There was extensive lung, liver, and kidney damage along with moderate gastritis in rats in the acute oral toxicity test.

Attached is a data sheet prepared by Olson and McCollister, a toxicology work sheet, “Request For Applications Testing”, and acute oral toxicity, eye contact, skin contact – irritation and single exposure test records. NOTE: The document is stamped, “This Report Is The Property Of The Dow Chemical Company.”

.

Trial Exhibit #: 84
Date: 12/24/57
Title: DOW CHEMICAL TESTING OF SILICONES IN BREAST IMPLANTS RELIANCE ON DOW CHEMICAL
Information: Letter from K.J. Olson and checked by D.D. McCollister, Dow Chemical Biochemical Research, to R.R. McGregor of Dow Corning with copies to J.H. McHard and H.H. Gay [Dow Chemical] on “Comparison Of 200 Fluid, Treated And Untreated, Insofar As Eye Contact Irritation Is Concerned.” McGregor recently submitted 2 samples of 200 Fluid for toxicological evaluation for eye contact irritation. Neither materials showed any marked irritating properties when instilled directly into the rabbit eye.

Attached is a data sheet prepared by Olson and McCollister, a toxicology work sheet, “Request For Applications Testing,” and eye contact test records. NOTE: The document is stamped, “This Report Is The Property Of The Dow Chemical Company.”

.

Trial Exhibit #: 85
Date: 03/28/58
Title: DOW CHEMICAL TESTING OF SILICONES IN BREAST IMPLANTS KNOWLEDGE OF LIQUID SILICONE DANGERS RELIANCE ON DOW CHEMICAL
Information: Report from J.K. Weiler, Dow Corning Analytical Laboratory, to H.J. Horner with copies to Olson of Dow Chemical, McGregor, File, and Weiler concerning “Determination of the Amounts of Silicone Fluid Retained by Various Internal Organs of Rabbits after Intravenous Injection of Material Containing Silicone Fluid.” Horner writes, “Upon checking with Dr. McGregor I find this work has been temporarily suspended but not abandoned. Apparently they have been considering using some labeled 200 fluid. My future work will again be initiated by Dr. McGregor.”

Attached is a Dow Chemical “Request For Applications Testing” on DC 710 fluid, a Dow Chemical “Request For Biological Test” on DC 555 Fluid on human subjects signed by V.K. Rowe, a Dow Chemical “Request For Applications Testing” on DC XF-6060, a Dow Chemical “Request For Applications Testing” on DC XEC-5021, a Dow Chemical “Request For Applications Testing” on DC XF-371, and a Dow Chemical “Request For Applications Testing” on DC 555 fluid.

NOTE: The documents on human testing of DC 555 Fluid by Rowe were not produced in MDL 926

.

Trial Exhibit #: 87
Date: 07/31/58
Title: BIOLOGICAL ACTIVITY OF SILICONES COMPLICATIONS: TISSUE REACTION KNOWLEDGE OF SYSTEMIC DISEASE RELIANCE ON DOW CHEMICAL
Information: Olson, Dow Chemical Biochemical Research, letter to McGregor, Dow Corning, with copies to Gay, Dow Chemical, and McHard regarding the results of skin irritation, skin absorption, and acute oral feeding tests on Dow Corning 555 Fluid and Ethylan (a modified lanolin), File No. T2.42-54-1.

In McGregor’s 06/05/58 letter to Rowe, he indicated that Helen Curtis Industries had observed untoward systemic effects in rabbits and rats due to absorption of the material through the skin. Autopsy revealed small yellowish bubbles and petochone [illegible] on the liver and lungs. Olson applied the material to the skin of rabbits and fed it to another group for 5 days. The results for the skin sensitization tests are illegible. There was questionable to mild kidney disturbance in animals fed DC 555 fluid.

The conclusions on TDC 6532 state that DC 555 fluid has a low acute oral toxicity, is essentially non-irritating to the skin upon prolonged repeated contact, and that there is no indication that the material is absorbed through the skin in sufficient amounts to produce systemic damage. Attached is a toxicology work sheet, “Request For Screening Or Applications Testing.” and skin contact absorption and acute oral toxicity test results.

.

Trial Exhibit #: 89
Date: 09/01/59
Title: BIOLOGICAL ACTIVITY OF SILICONES COMPLICATIONS: TISSUE REACTION DOW CHEMICAL TESTING OF SILICONE IN BREAST IMPLANTS LOW MOLECULAR WEIGHT EXTRACTABLES
RELIANCE ON DOW CHEMICAL
Information: Letter from K.J. Olson and checked by F. Oyen, Dow Chemical Biochemical Research, to R.R. McGregor with a copy to J.H. McHard on “Comparative Eye Irritation Of Specially Prepared Dow Corning 200 Fluids.” On the bottom of TDC 6208 there is a handwritten note: “V.K. Rowe says physiological action of 200 fluid [is] the result of physical forces rather than chemical, i.e. the eye discomfort may be due to lowering of surface tension.” The commercial 200 fluid manifested very slight but definite conjunctival irritation. The dimethyl cyclic tetramer (includes results of D4 studies) had consistent, slight to moderate irritation in both rabbits which was significantly worse than the commercial 200 fluid. The dimethyl linear material and the HO(Me2SiO)H are essentially non-irritating.

NOTE: Dow Chemical is providing advice and recommendations to Dow Corning.

.

Trial Exhibit #: 90
Date: 03/10/60
Title: BIOLOGICAL ACTIVITY OF SILICONES DOW CHEMICAL TESTING OF DOW CORNING PRODUCTS RELIANCE ON DOW CHEMICAL
Information: Letter from T.R. Torkelson, Dow Chemical Biochemical Research, to R.R. McGregor of Dow Corning with copies to J.A. McHard, H.H. Gay [Dow Chemical], and V.K. Rowe [Dow Chemical] on “The Toxicity To Rats Of Vapors Resulting From Decomposition Of Three Silicon Rubbers By Heat (A995-46-1, 2, and 3).” Sample 3 was considerably more toxic when decomposed than the other two. Rats died within 3 days in some tests, in 4 hours in others because of lung irritation and congestion, and in 2 weeks in another test. Lung, liver, and kidney pathology were seen at autopsy.

.

Trial Exhibit #: 91
Date: 09/26/60
Title: BIOLOGICAL ACTIVITY OF SILICONES DOW CHEMICAL TESTING OF DOW CORNING PRODUCTS RELIANCE ON DOW CHEMICAL
Information: Letter from K.J. Olson and checked by F. Oyen, Dow Chemical Biochemical Research, to R.R. McGregor of Dow Corning with a copy to J.A. McHard on “Results Of Range Finding Toxicological Tests On Tin Dioctoate (XY-70 Catalyst) [material is supplied by Nuodex as Silicure T 773 and that it is used as a 1% concentration to catalyze your Room Temperature Vulcanizing Silastic. “This silastic in turn is of interest to the medical profession.”].” The material was fed to rats in 2g/kg body weight and did not produce any deaths. The material has a low acute oral toxicity. Gross pathology showed considerable kidney and liver injury along with gastrointestinal irritation and general congestion. The undiluted catalyst is moderately to severely irritating to the eye, and slightly irritating to the skin.

.

Trial Exhibit #: 94
Date: 08/31/61
Title: DOW CHEMICAL TESTING OF DOW CORNING PRODUCTS – HERBICIDE RELIANCE ON DOW CHEMICAL
Information: Letter from K.J. Olson and checked by F. Oyen, Dow Chemical Biochemical Research, to Jim McHard of Dow Corning on “Results Of Range Finding Toxicological Tests On Chloromethyl Methyl Siloxane Hydrolysate (Ref: A-1065-94-2).” The material is said to be a grass killer. The material has a low acute oral toxicity, is slightly irritating to the eyes, and slightly irritating to the skin.

.

Trial Exhibit #: 96
Date: 04/11/62
Title: DOW CHEMICAL TESTING OF DOW CORNING PRODUCTS – HERBICIDE, DEFOLIANT RELIANCE ON DOW CHEMICAL
Information: Letter from Olson, Dow Chemical’s Biochemical Research Laboratory (Bldg. 1701), to McHard of Dow Corning regarding “Results of Range Finding Toxicological Tests On Chloromethyl Methyl Dimethoxy Silane.” The material “is generally effective as an herbicide and specifically effective as a defolient [sic].” A copy of the letter was sent to K. Leasure, K. Barrons [Dow Chemical Bioproducts Plt. Sci R and D], and G.E. Lynn [Dow Chemical Bioproducts Registration Section]. The material has a low acute oral toxicity and is only slightly irritating to the eye. Direct contact would likely be somewhat painful and produce slight conjunctival redness. There is indication from skin irritation and absorption studies conducted on rabbits that the material possesses a low order of toxicity by absorption through the skin particularly if abraded. The material also possesses a relatively high vapor pressure and poses a problem from the viewpoint of vapor inhalation. Laboratory rats survived 1 hour but did not survive 2 hours. “It is possible under conditions of room temperature to become exposed to vapors sufficient to result in systemic injury.”

On TDC 7457, there is a note re K. Leasure’s report. “Dow may handle marketing.” McHard requested the testing. Also, there is a reference to Stage 2 (??) testing; send report to Leasure and Barrons – confidential.

.

Trial Exhibit #: 99
Date: 07/05/62
Title: BIOLOGICAL ACTIVITY OF SILICONES COMPLICATIONS: TISSUE REACTION DOW CHEMICAL TESTING OF SILICONES IN BREAST IMPLANTS RELIANCE ON DOW CHEMICAL
Information: Olson and Sadek, Dow Chemical Biochemical Research, letter to McHard, Dow Corning, on “Toxicity By Subcutaneous Injection Of Dow Corning 200 Fluids And Dow Corning 555 And 550 Fluids.” Dow Corning 200 fluid 10cs. resulted in a moderate inflammatory response in the subcutis as indicated by the presence of polymorphonuclear cells and very large mononuclear cells. “This type of inflammatory reactions is interpreted as due to infection.” With DC 555 Fluid, all injection sites showed evidence of inflammatory reaction by the presence by mononuclear cells and polymorphonuclear cells.

.

Trial Exhibit #: 101
Date: 09/14/62
Title: BIOLOGICAL ACTIVITY OF SILICONES COMPLICATIONS: TISSUE REACTION DOW CHEMICAL TESTING OF SILICONES IN BREAST IMPLANTS
Information: Dow Chemical Texas Division, Agricultural Research, study by F.C. Turner, K.G. Seymour, and J.B. Jackson on “Topical Application Of Various Solvents And Solutions To Evaluate Dermal Irritation,” Report No. 210. The report was circulated to many persons including K.W. McCoy of Dow International; persons at Bioproducts: Adm., J.E. Johnson; An. Sci. R and D, T.A. Hymas; Plt. Sci. R and D, K.C. Barrons; Midland BRC Files, L.J. Lippie; Registration Section, G.E. Lynn; Synthesis Group, W. Reifschneider; and Formulation Res., J.W. Valkenburg; to V.K. Rowe of Biochemical Research; and to the following persons at Pitman-Moore: C.W. Hinman, G.R. Burch, and D.C. Brinkman. Dow Corning 200 fluid – silicone oil with 49% espesol 5 content was administered in 10 cc dosages to shaved strips on the hide to test for suitable solvents for Ruelene. Dow Chemical hoped to find a solvent that didn’t damage the hides of cattle when Ruelene was administered. The DC 200 fluid was rated as bad, which indicated that the hide had extreme cracking or sloughing at 10 and 16 days after application.

.

Trial Exhibit #: 105
Date: 10/31/63
Title: GEL MIGRATION KNOWLEDGE OF LIQUID SILICONE DANGERS
Information: Dr. Walter Berman writes to Silas Braley, Dow Corning, reporting on his injection of silicone fluid in mice. Two days after injection, silicone was found in most organs including the brain, liver, spleen, intestinal wall, adrenal, and kidney. He also found “evidence of at least radioactivity and most probably silicone in the brain and all the various other organs…”

.

Trial Exhibit #: 253
Date: 02/10/72
Title: CONCEALMENT DOW CHEMICAL TESTING OF SILICONES IN BREAST IMPLANTS FRAUD/MISREPRESENTATION RELIANCE ON DOW CHEMICAL
Information: “The Effects of Dow Corning 360 Medical Fluid, 350 CS And Sesame Oil After Intraperitoneal Or Subcutaneous Administration To Rats,” by E.J. Hobbs, Dow Corning Toxicology Department. This report is a retyped version of the 12/02/70 study done by Sparschu and Clashman of Dow Chemical. The differences in the reports are:
1.    In the introductory paragraph, Hobbs states that this study was initiated to reproduce findings in a recent publication authorized by Hawthorne, Ballantyne, and Rees entitled, “Hematological Effects of Dimethlpolysiloxane Fluid in Rats,” J. of Reticuloendothelial Soc., Vol. 7, 587-593 (1970). The “Hawthorne” study revealed “an unexpected hematological finding manifested by multiple vacuoles in red cells of rats following intraperitoneal (I.P.) injection with massive doses of dimethylpolysiloxane.

2.    On DCC 243000005, Dow Corning refers to “injections” given to the test animals. In the Dow Chemical report, it states on T 38868 that a single injection was given.

3.    The table on DCC 243000005 notes that the test animals were reviewed for 401 days. In the Dow Chemical report, it states on T 38868 that the animals were reviewed for 481 days.

4.    Dow Corning has deleted the paragraph on T 38869 that Dow Chemical performed the hematology, urinalysis, clinical chemistry, and gross and histopathology studies.

NOTE: This Dow Corning generated cover sheet, which was submitted to the FDA in 1991 as part of the Dow Corning’s Premarket Approval Application, claims that this was an “internal Dow Corning study.”

.

Trial Exhibit #: 255
Date: 04/07/72
Title: GEL MIGRATION
Information: “Dimethylpolysiloxane Fluid C (Dow Corning 360 Medical Fluid C) Distribution and Disposition In Rats Following Subcutaneous Injection.” by LeBeau and Gorzinski of the Bioscience Research Department of DC. A copy was sent to Ryan, Bennett, Braley, Hunter, Isquith, Frye, LeVier, Speier, Stark, Boley, and others. DC 360 fluid was administered subcutaneously to rats to measure the distribution of the fluid in expired air, urine, and feces at 8, 30, 60, and 90 days. The highest percentage (>94%) was detected at the original injection site. Less than 10 percent (<10%) was detected in urine and feces. “There was a ubiquitous distribution of low concentrations of radioactivity in the tissues and organs (<.02%). However, lymphatic tissue near the injection site had a higher (ten-fold) concentration of radioactivity of all tissues and organs examined suggesting migration via lymphatic routes.”

Rodents receiving massive subcutaneous doses of silicone fluid were examined histopathologically. Droplets of vacuoles were found throughout the reticuloendothelia systems including the regional lymph nodes and extending to the liver, spleen, kidneys, and adrenals. Definite proof of silicone fluid in the droplets was not demonstrated but the authors assumed it was silicone fluid.

NOTE: LeBeau later joined Dow Chemical to head up its toxicology department.

.

Trial Exhibit #: 562
Date: 05/14/82
Title: COMPLICATIONS: TISSUE REACTION GEL MIGRATION IMMUNOLOGY KNOWLEDGE OF SYSTEMIC DISEASE RECKLESS/CONSCIOUS DISREGARD SHELL DEGRADATION
Information: Dr. Robert Parsons, Professor of Surgery at the University of Chicago, writes a letter to Gene Jakubczak at Dow Corning informing them of their research on implanted silicone prostheses. “Our data suggest strongly that the fibrosis and capsular contracture seen clinically may be an immunologically mediated phenomenon.” Dr. Parsons states that macrophages aggregate and adhere to the surface and actively erode the silicone envelope after implantation; macrophages ingest and process silicone; macrophage-lymphocyte communication occurs by intracellular bridging in the lymph nodes and have identified silicone containing microvacuoles in both the macrophage and lymphocyte ends of the bridges; and significant inhibition of macrophage migration by silicone sensitized lymphocytes in vitro has been shown. Dr. Parsons, Dr. Heggers, and their research assistant, Nir Kossovsky, suggest that their work may enable them to develop a method of screening patients for “hypersensitivity to silicone” before they are implanted.
The research team found that the body’s reaction to silicone created giant cells called macrophages that erode the silicone envelope and can migrate to the lymph nodes. Dr. Parsons believes that the body’s immune reaction could be causing such problems as capsular contracture. Requests for funding from Dow Corning to further research to better understand this immune response were denied by the company.

.

Trial Exhibit #: 577
Date: 00/00/83
Title: RELIANCE ON DOW CHEMICAL SILICONE IS INERT MYTH
Information: “Technology of Silicones in Biomedical Applications.” Chapter 8 in Biomaterials in Reconstructive Surgery, by Eldon Frisch of Dow Corning. Frisch cites the November 1948 Rowe, Spencer, Bass article.

.

Trial Exhibit #: 624
Date: 08/01/84
Title: CONCEALMENT – SECRECY AGREEMENT INSECTICIDES JOINT VENTURE/CORPORATE CONTROL
Information: Joint Research Agreement For Identification Of Agricultural Chemicals between Dow Corning (signed by Weyenberg) and Dow Chemical (signed by P. Gehring). Dow Chemical produces and sells pesticides, herbicides, insecticides, acaricides, nematocides, and fungicides and has developed expertise in perceiving structural-activity relationships in non-organosilicon compounds. Dow Corning has expertise in the synthesis and manufacture of organosilicon compounds referred to as silicones. The parties will work together to “identify commercially salable organosilicon compounds and formulations thereof with biological activity as pesticides in the agricultural chemical field…” (DCC 2001173) Dow Corning appoints Dr. John Ryan as its representative; Dow Chemical appoints Dr. Yulan Tong.

The Joint Research Program will begin with one or more meetings between the designated representatives. Dow Chemical will disclose the type of pesticides it seeks to develop and the kinds of chemical structural groups that DOW believes impart desired agricultural chemical properties. The parties may select compounds for screen tests by Dow Chemical. The designated representatives shall generate a plan for conduct of the Joint Research Program. The information developed under this program shall be kept confidential for 10 years.

.

Trial Exhibit #: 692
Date: 07/06/87
Title: CONCEALMENT – SECRECY AGREEMENT INSECTICIDES
Information: Weyenberg and Geyring letter to Shilling regarding joint research agreement for identification of agricultural chemicals – modification of item 10 (changing agreement from 3 years to 4) and amendment specifying subsidiaries of the parties may receive information exchanged under their agreement and who may be employed to conduct work on the program.

.

Trial Exhibit #: 734
Date: 12/20/89
Title: CONCEALMENT – SECRET AGREEMENT RELIANCE ON DOW CHEMICAL
Information: Letter agreement between Dow Corning and Dow Chemical (signed by LeBeau, a former Dow Corning scientist) for Dow Chemical to audit Dow Corning’s Health and Environmental Services Lab (formerly known as the Toxicology Lab) for Good Laboratory Practices compliance. Dow Chemical agrees to keep any information it learns from the audit secret for 10 years and shall inform its employees only on a “need to know” basis.

.

Trial Exhibit #:
Date:
Title:
Information:

6 Responses to DOW Chemical

  1. Gigi says:

    Dear friends Addela & Richard,
    The informaton on your website, is outstanding, and will help us all hold, Dow
    Chemical Liable for the horrendous crimes commited against humans. Dow knew
    an intentionally hid their own evidence, which proved they were guilty of mnufacturing a toxic, faulty medical device. Which has killed numerious persons
    with cancer, others became ill with various diseases such as MS Lupus, immune
    diseases, stomach problems, and severe neurological damage. We’ve received no
    justice throught the court systems, but websites likes yours will help future generatons of women hunting the truth concerning breast implants Dow lied about!!

    Gigi

    th

  2. Gigi says:

    Dear friends Addela & Richard,
    The informaton on your website, is outstanding, and will help us all hold, Dow
    Chemical Liable for the horrendous crimes commited against humans. Dow knew
    an intentionally hid their own evidence, which proved they were guilty of mnufacturing a toxic, faulty medical device. Which has killed numerious persons
    with cancer, others became ill with various diseases such as MS Lupus, immune
    diseases, stomach problems, and severe neurological damage. We’ve received no
    justice throught the court systems, but websites likes yours will help future generatons of women hunting the truth concerning breast implants Dow lied about!!
    Thank you sincerely for your hard work, I’ll be sending my friends to your, website
    tomorrow, when I send out news. What a pleasure to read the true documents, and
    court papers against, evil Dow Chemical & Dow Corning on the web again, where they
    won’t be removed ever. I’ll send this to many of my attorney friends also, an every
    women to read & Pass on too. What an amazing website & some U tubes you, both
    have accomplished for the victims of, Dow & every breast implant made! Dow started this rain of terror on perons, not caring, whom they harmed (killed in the process) then
    bought off judges & persons in the presss, medical institues; made it impossible to have a jury trial! The women in other countries received less money, Dow after 15
    long years, still hasn’t paid their victims in the; USA!! Many other breast implants
    companies, got by without paying their severely harmed victims hardly a red cent!
    Dow poisoned the, Agent Orange Vets, how many persons, is our goverment going
    to allow; Dow to harm severely without stoping Dow Chemical? Dow Chemical blamed
    their egerious lies & harm on, Dow Corning. ( we all know Dow Chemical is responsible
    for this) Dow Chemical ran all the tests in their own labs, & then hide the incrimianting
    evidence themselves dead rats, beagles, guiena pigs & highly toxic silicone & other
    chemicals added don’t lie; Dow Chemical Does!

    Blessings to you, Addela & Richard ~
    Gigi

  3. June Byrd says:

    I have Breast Implants, since 1975. One of them just developed a leak. I am on medicare now and I was wondering if some of the cost of removing them would be covered by medicare.I haven’t had any problems in the 36 years that I have had them. I didn’t get in on any of the law suits back when they were available. Can you help me?

  4. Adella says:

    Thank you for contacting me Gigi. My heart goes out to you, with your sincere problems. I am happy our website helps women like you.

  5. Adella says:

    So sorry for the late reply, we had issues with our website and are just finding these messages now.
    It sounds as though you are in the USA. Let us know where you live so I can direct you to a Dr. who can do the explant surgery correctly.

  6. Anonymous says:

    Pretty! This was an extremely wonderful article. Thank you for providing this information.

Leave a Reply

Your email address will not be published. Required fields are marked *